ÂÜÀòÂÒÂ×

Jens Wuerthner, MD PhD has a diverse work experience spanning various roles and organizations. Jens is currently serving as the Chief Medical Officer at Scenic Biotech since October 2022. Prior to this, they worked as the Visiting Professor at King's College - London starting from 2012. Jens also held the position of Fellow at the Faculty of Pharmaceutical Medicine from 2006.

Dr. Wuerthner has a strong background in clinical development and leadership roles in the pharmaceutical industry. Jens worked at ADC Therapeutics, where they served as the Vice President and Head of Global Clinical Development from January 2020 to October 2022, and as the Associate Vice President and Head of Clinical Development - EU from June 2016 to January 2020.

Before their tenure at ADC Therapeutics, Dr. Wuerthner worked at Novartis as a Clinical Program Leader from 2011 to May 2016 and at GSK as the Director of Biopharm R&D Translational Pharmacology and Discovery Medicine from March 2009 to October 2011. Jens also held the position of Honorary Lecturer at the University of Manchester from 2008 to 2011.

Dr. Wuerthner started their industry career at AstraZeneca as an Oncology Research Physician from January 2006 to February 2009.

Overall, Dr. Jens Wuerthner has a wealth of experience in clinical development, leadership, and academia, making him a highly experienced and well-rounded professional in the healthcare industry.

Jens Wuerthner, MD PhD attended the University of Hamburg for an undisclosed period of time. Jens also attended Bismarck Gymnasium, although the duration of their studies there is unspecified. Later, Jens Wuerthner pursued further education at Harvard Medical School. However, the specific degrees attained and fields of study remain unknown.